Newborn screening for Duchenne muscular dystrophy: A two-year pilot study.

Annals of clinical and translational neurology(2023)

Cited 2|Views13
No score
Abstract
This study demonstrated that the state NBS program infrastructure and screening technologies we used are feasible to perform NBS for DMD. With an increasing number of treatment options, the clinical utility of early identification for affected newborns and their families lends support for NBS for this severe disease.
More
Translated text
Key words
muscular dystrophy,newborn,screening,duchenne
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined